1. Home
  2. GKOS vs CPB Comparison

GKOS vs CPB Comparison

Compare GKOS & CPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$102.43

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Campbell Soup Company

CPB

Campbell Soup Company

HOLD

Current Price

$21.07

Market Cap

6.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
CPB
Founded
1998
1869
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
6.2B
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
GKOS
CPB
Price
$102.43
$21.07
Analyst Decision
Strong Buy
Hold
Analyst Count
12
18
Target Price
$126.92
$26.06
AVG Volume (30 Days)
1.0M
6.5M
Earning Date
04-29-2026
06-01-2026
Dividend Yield
N/A
7.63%
EPS Growth
N/A
6.35
EPS
N/A
1.13
Revenue
$507,442,000.00
$10,253,000,000.00
Revenue This Year
$23.32
N/A
Revenue Next Year
$27.43
$0.11
P/E Ratio
N/A
$18.43
Revenue Growth
32.33
6.40
52 Week Low
$73.16
$19.56
52 Week High
$148.11
$35.00

Technical Indicators

Market Signals
Indicator
GKOS
CPB
Relative Strength Index (RSI) 28.38 55.48
Support Level $92.38 $19.78
Resistance Level $102.80 $21.31
Average True Range (ATR) 7.36 0.63
MACD -4.94 0.12
Stochastic Oscillator 1.08 82.09

Price Performance

Historical Comparison
GKOS
CPB

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About CPB Campbell Soup Company

Over the past 150-plus years, Campbell's has evolved into a leading domestic packaged food manufacturer, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2025 (July year-end), snacks accounted for 43% of its revenue, followed by soup (27%), other simple meals (23%), and beverages (7%). Beyond its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and, most recently, Rao's (a deal that closed in 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.

Share on Social Networks: